TY - JOUR
T1 - Population pharmacokinetics of lidocaine in Korean adults during general anesthesia
AU - Lee, K. H.
AU - Park, K.
AU - Kang, J. H.
AU - Baek, H. M.
AU - Roh, H. K.
AU - Cha, Y. N.
PY - 1999
Y1 - 1999
N2 - Population pharmacokinetics of lidocaine (L) was determined in Korean adults during general anesthesia with enflurane, nitrous oxide, and oxygen (50%). After induction of anesthesia, tracheal intubation, and insertion of venous and arterial catheters, L was administered by intravenous bolus at 1, 2 or 3 mg/kg. Various times after dosing with L, 182 blood samples were obtained from contralateral radial artery of 23 individuals. L concentrations in plasma were determined by immunofluorescence assay. Concentration-time data were analyzed using a 2-compartment open model by NONMEM, allowing for interindividual differences. Fit of the model from all individuals gave following estimated values; distribution half-life (t1/2α) of 0.49 min (interindividual variability; 16% in CV), elimination half-life (t1/2β) of 18.68 min (20%), clearance of 13.4 mL/min/kg (20%), central volume of distribution (VC) of 27.9 mL/kg (22%), and steady-state volume of distribution (VSS) of 279.1 mL/kg (39%). These parameters showed considerable differences from those reported earlier for other population.
AB - Population pharmacokinetics of lidocaine (L) was determined in Korean adults during general anesthesia with enflurane, nitrous oxide, and oxygen (50%). After induction of anesthesia, tracheal intubation, and insertion of venous and arterial catheters, L was administered by intravenous bolus at 1, 2 or 3 mg/kg. Various times after dosing with L, 182 blood samples were obtained from contralateral radial artery of 23 individuals. L concentrations in plasma were determined by immunofluorescence assay. Concentration-time data were analyzed using a 2-compartment open model by NONMEM, allowing for interindividual differences. Fit of the model from all individuals gave following estimated values; distribution half-life (t1/2α) of 0.49 min (interindividual variability; 16% in CV), elimination half-life (t1/2β) of 18.68 min (20%), clearance of 13.4 mL/min/kg (20%), central volume of distribution (VC) of 27.9 mL/kg (22%), and steady-state volume of distribution (VSS) of 279.1 mL/kg (39%). These parameters showed considerable differences from those reported earlier for other population.
UR - http://www.scopus.com/inward/record.url?scp=33749087474&partnerID=8YFLogxK
U2 - 10.1016/S0009-9236(99)80241-0
DO - 10.1016/S0009-9236(99)80241-0
M3 - Article
AN - SCOPUS:33749087474
SN - 0009-9236
VL - 65
SP - 177
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
IS - 2
ER -